California startup Protuoso raises $9.5m for “mix-and-match” drug platform - Pharmaceutical Technology

The US biotech’s technology integrates multiple protein modalities to simultaneously target a variety of disease mechanisms. The US biotech’s technology integrates multiple protein modalities to simultaneously target a variety of disease mechanisms. Founded by Willie Xiang and Tim Lu in California, the biotech is developing multifunctional biologics using what it calls MUXBODIES. Credit: Protuoso Bio via BusinessWire. Protuoso Biosciences has secured $9.5m in seed financing to develop its platform which combines multiple therapeutic modalities to target diseases through several pathways simultaneously. Founded by Willie Xiang and Tim Lu in California, the biotech is developing multifunctional biologics using what it calls…

Source: Pharmaceutical Technology